• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NDF/神经调节蛋白诱导的乳腺肿瘤细胞周期变化及凋亡:PI3激酶和p38丝裂原活化蛋白激酶信号通路的作用

NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.

作者信息

Daly J M, Olayioye M A, Wong A M, Neve R, Lane H A, Maurer F G, Hynes N E

机构信息

Friedrich Miescher Institute, Basel, Switzerland.

出版信息

Oncogene. 1999 Jun 10;18(23):3440-51. doi: 10.1038/sj.onc.1202700.

DOI:10.1038/sj.onc.1202700
PMID:10376522
Abstract

Neu differentiation factor (NDF)/heregulin activates ErbB2 via heterodimerization with the NDF receptors ErbB3 and ErbB4. Cells which express normal levels of these receptors are often growth stimulated by NDF, whereas SKBR3, and other ErbB2-overexpressing breast tumour cells are growth inhibited. We demonstrate here that in SKBR3 cells, NDF induces G1 progression but also causes a G2 delay from day 1 and apoptosis from days 2-3. G1 progression was associated with ErbB2 transactivation of ErbB3 and subsequent stimulation of the phosphatidylinositol 3-kinase (PI3K) pathway whereas apoptosis was dependent on p38 MAPK. Inhibition of ERK1/ERK2 had no effect on cell cycle progression or apoptosis. Activation of ErbB3 and PI3K was also seen with betacellulin (BTC) but not epidermal growth factor (EGF) and correlated with the growth effects of these ligands. All three ligands induced short-term activation of p38 MAPK in a c-Src-dependent manner. However, only NDF caused a second, c-Src-independent increase in p38 MAPK activity which was required for apoptosis.

摘要

神经分化因子(NDF)/ 神经调节蛋白通过与NDF受体ErbB3和ErbB4异源二聚化来激活ErbB2。表达这些受体正常水平的细胞通常会被NDF刺激生长,而SKBR3细胞以及其他过表达ErbB2的乳腺肿瘤细胞则生长受抑制。我们在此证明,在SKBR3细胞中,NDF诱导G1期进程,但也会从第1天开始导致G2期延迟,并从第2 - 3天开始引发细胞凋亡。G1期进程与ErbB2对ErbB3的反式激活以及随后对磷脂酰肌醇3激酶(PI3K)途径的刺激有关,而细胞凋亡则依赖于p38丝裂原活化蛋白激酶(MAPK)。抑制细胞外信号调节激酶1/2(ERK1/ERK2)对细胞周期进程或细胞凋亡没有影响。β细胞素(BTC)也能激活ErbB3和PI3K,但表皮生长因子(EGF)不能,且这与这些配体的生长效应相关。所有三种配体均以c - Src依赖的方式诱导p38 MAPK的短期激活。然而,只有NDF会导致p38 MAPK活性出现第二次、不依赖c - Src的增加,而这是细胞凋亡所必需的。

相似文献

1
NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.NDF/神经调节蛋白诱导的乳腺肿瘤细胞周期变化及凋亡:PI3激酶和p38丝裂原活化蛋白激酶信号通路的作用
Oncogene. 1999 Jun 10;18(23):3440-51. doi: 10.1038/sj.onc.1202700.
2
ErbB kinases and NDF signaling in human prostate cancer cells.人前列腺癌细胞中的表皮生长因子受体(ErbB)激酶与神经分化因子(NDF)信号传导
Oncogene. 1997 Nov 27;15(22):2705-16. doi: 10.1038/sj.onc.1201447.
3
Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells.神经分化因子诱导ErbB2过表达的乳腺肿瘤细胞中ErbB2下调并凋亡。
Cancer Res. 1997 Sep 1;57(17):3804-11.
4
Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.赫赛汀β1激活的磷脂酰肌醇3激酶增强MCF-7乳腺癌细胞的聚集,且不依赖于细胞外信号调节激酶。
Cancer Res. 1999 Apr 1;59(7):1620-5.
5
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.表皮生长因子相关肽的可获得性会影响表皮生长因子受体靶向抗癌疗法的疗效。
Cancer Res. 2002 Jun 1;62(11):3151-8.
6
Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.在有丝分裂期间,神经分化因子/神经调节蛋白可有效诱导p185erbB - 2和erbB - 3募集磷脂酰肌醇3 -激酶,并且在具有c - erbB - 2基因扩增的不依赖生长因子的乳腺癌细胞中,该过程持续增强。
Cell Growth Differ. 1996 May;7(5):551-61.
7
Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.响应特定癌基因时,乳腺致癌作用所激活并需要的信号转导通路。
Oncogene. 1998 Feb 12;16(6):737-46. doi: 10.1038/sj.onc.1201829.
8
Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.表皮生长因子和β细胞素通过共同表达的ErbB2和ErbB3受体介导信号转导。
EMBO J. 1997 Sep 15;16(18):5608-17. doi: 10.1093/emboj/16.18.5608.
9
Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.乳腺肿瘤激酶(蛋白酪氨酸激酶6)调节乳腺癌细胞中由神经调节蛋白诱导的细胞外信号调节激酶5(ERK5)和p38丝裂原活化蛋白激酶(p38 MAPK)的激活。
Cancer Res. 2007 May 1;67(9):4199-209. doi: 10.1158/0008-5472.CAN-06-3409.
10
Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.神经分化因子/神经调节蛋白调节HC11乳腺上皮细胞的生长和分化。
Mol Endocrinol. 1995 Jan;9(1):14-23. doi: 10.1210/mend.9.1.7760847.

引用本文的文献

1
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives.曲妥珠单抗在胃食管癌治疗中的应用:患者选择与展望
Onco Targets Ther. 2016 Nov 25;9:7235-7245. doi: 10.2147/OTT.S100643. eCollection 2016.
2
Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.赛庚啶是一种抗组胺药,它通过激活P38丝裂原活化蛋白激酶来阻断细胞周期进程,从而抑制肝癌细胞的增殖。
BMC Cancer. 2015 Mar 17;15:134. doi: 10.1186/s12885-015-1137-9.
3
The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.
乳腺癌中的HER2信号网络——宛如蛛网中的蜘蛛
J Mammary Gland Biol Neoplasia. 2014 Dec;19(3-4):253-70. doi: 10.1007/s10911-014-9329-5. Epub 2014 Dec 28.
4
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.靶向ErbB-2核定位及功能可抑制乳腺癌生长并克服曲妥珠单抗耐药性。
Oncogene. 2015 Jun;34(26):3413-28. doi: 10.1038/onc.2014.272. Epub 2014 Sep 1.
5
Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.Heregulin 通过 AKT 介导的途径负调控 ErbB2/3 受体的转录。
J Cell Physiol. 2014 Nov;229(11):1831-41. doi: 10.1002/jcp.24637.
6
Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer.曲妥珠单抗:HER-2 阳性晚期胃癌或胃食管结合部癌患者的新型标准选择。
Therap Adv Gastroenterol. 2012 Sep;5(5):301-18. doi: 10.1177/1756283X12450246.
7
Synergistic interactions between heregulin and peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist in breast cancer cells.在乳腺癌细胞中,肝素结合生长因子和过氧化物酶体增殖物激活受体-γ(PPARγ)激动剂的协同相互作用。
J Biol Chem. 2011 Jun 3;286(22):20087-99. doi: 10.1074/jbc.M110.191718. Epub 2011 Apr 5.
8
c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest.c-Cbl酪氨酸激酶结合结构域突变体G306E消除了c-Cbl与CD38的相互作用,并且无法促进视黄酸诱导的细胞分化和G0期停滞。
J Biol Chem. 2009 Sep 18;284(38):25664-77. doi: 10.1074/jbc.M109.014241. Epub 2009 Jul 27.
9
3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status.3,3'-二吲哚甲烷可诱导人前列腺癌细胞出现G(1)期阻滞,且与雄激素受体和p53状态无关。
Biochem Pharmacol. 2009 Sep 1;78(5):469-76. doi: 10.1016/j.bcp.2009.05.008. Epub 2009 May 9.
10
Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman.去卵巢大鼠和绝经后女性阴道对雌激素反应的分子分析。
BMC Med Genomics. 2008 Jun 25;1:27. doi: 10.1186/1755-8794-1-27.